Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with <i>AVPR2</i> mutation: a case report.

Ikegawa, Kento; Hachiya, Rumi; Akiba, Kazuhisa; Hasegawa, Yukihiro

Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.

Ikegawa, Kento; Hachiya, Rumi; Akiba, Kazuhisa; Hasegawa, Yukihiro.

Afiliación

Ikegawa K; Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Hachiya R; Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Akiba K; Division of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Hasegawa Y; Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.

Clin Pediatr Endocrinol ; 31(2): 87-92, 2022.

Article en En | MEDLINE | ID: mdl-35431445

Palabras clave

AVPR2; congenital nephrogenic diabetes insipidus; oral disintegrating 1-deamino-8-D-arginine vasopressin (DDAVP); partial nephrogenic diabetes insipidus (NDI)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Pediatr Endocrinol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google